GO:0097057 TRAF2-GSTP1 complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0097057 describes the TRAF2-GSTP1 complex, a cellular_component comprising tumor necrosis factor receptor-associated factor 2 (TRAF2) and glutathione S-transferase pi 1 (GSTP1).
• The complex is thought to disrupt the TNF signaling cascade, thereby down-regulating inflammatory responses.
• The TRAF2-GSTP1 interaction is fine-tuned by ligand binding, and the complex can be detected in situ.
• Nitrobenzoxadiazoles can activate c-Jun N-terminal kinase (JNK) and lead to late-stage autophagy inhibition, a process linked to GSTP1 and TRAF2 signaling.
• Dysregulation of the TRAF2-GSTP1 complex may contribute to inflammatory diseases and cancer, making it a potential therapeutic target.
• Studying this complex requires tools such as knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics.
Description
The TRAF2-GSTP1 complex (GO:0097057) is a protein assembly that brings together two key players in cellular stress and immune signaling: tumor necrosis factor receptor-associated factor 2 (TRAF2) and glutathione S-transferase pi 1 (GSTP1). This complex is thought to act as a brake on the TNF signaling cascade, thereby dampening inflammatory responses. Understanding how TRAF2 and GSTP1 interact is therefore important for researchers studying inflammation, cancer, and cell survival. The interaction between TRAF2 and GSTP1 is not static; it is fine-tuned by ligand binding, and the complex can be visualized in situ, suggesting dynamic regulation in cells. Moreover, compounds such as nitrobenzoxadiazoles can activate JNK and inhibit late-stage autophagy, processes that intersect with GSTP1 and TRAF2 function. These findings highlight the complex as a node where redox regulation, inflammation, and autophagy converge. For researchers, GO:0097057 provides a precise annotation to study how a glutathione transferase and a TNF receptor adaptor cooperate to shape cell fate. This article reviews the definition, composition, regulation, disease relevance, and experimental strategies for investigating the TRAF2-GSTP1 complex, with a focus on CRISPR-based models and modern screening methods.
TRAF2-GSTP1 complex At A Glance
| GO ID | GO:0097057 |
|---|---|
| GO term | TRAF2-GSTP1 complex |
| Ontology | cellular_component |
| Synonym | None |
| Major function | Disruption of TNF signaling cascade, down-regulation of inflammatory responses |
| Complex members | TRAF2 and GSTP1 |
| Detection | Detectable in situ; interaction fine-tuned by ligand binding |
| Related process | JNK activation and late-stage autophagy inhibition by nitrobenzoxadiazoles |
What Is GO:0097057?
The TRAF2-GSTP1 complex is a cellular component defined by the Gene Ontology as a protein complex comprising tumor necrosis factor (TNF) receptor-associated factor 2 (TRAF2) and glutathione S-transferase pi 1 (GSTP1). This complex is thought to disrupt the TNF signaling cascade, thus down-regulating inflammatory responses. In other words, it is a physical assembly of two proteins that together modulate inflammatory signaling.
Why Is TRAF2-GSTP1 complex Important in Cell Biology?
The TRAF2-GSTP1 complex is important because it represents a direct molecular link between glutathione metabolism and TNF receptor signaling, two pathways central to inflammation and cell survival. By disrupting TNF signaling, the complex may help limit excessive inflammatory responses, and its dysregulation could contribute to chronic inflammation or cancer. Additionally, GSTP1 is a major detoxification enzyme, and its interaction with TRAF2 may integrate redox status with immune signaling. Understanding this complex could reveal new therapeutic strategies for diseases driven by TNF or oxidative stress.
• Provides a mechanism for cross-talk between glutathione metabolism and TNF signaling.
• May down-regulate inflammatory responses by disrupting TNF signaling.
• GSTP1 is a key detoxification enzyme, linking redox balance to immune regulation.
• TRAF2 is a central adaptor in TNF receptor signaling, affecting NF-kB and JNK pathways.
• The complex can be detected in situ, enabling spatial studies of its formation.
• Ligand binding fine-tunes the TRAF2-GSTP1 interaction, suggesting dynamic regulation.
• Nitrobenzoxadiazoles activate JNK and inhibit late-stage autophagy, intersecting with GSTP1/TRAF2 biology.
• Dysregulation may contribute to inflammatory diseases and cancer.
• Potential target for anti-inflammatory or anticancer therapies.
• Requires advanced models (KO, knock-in, overexpression) for functional dissection.
Structure and Composition of TRAF2-GSTP1 complex
TRAF2: The TNF Receptor Adaptor
In simple terms: TRAF2 is a protein that helps transmit signals from TNF receptors.
TRAF2 (tumor necrosis factor receptor-associated factor 2) is a key adaptor protein in the TNF signaling cascade. It contains a RING finger domain and zinc fingers, which enable it to interact with other proteins and regulate downstream pathways such as NF-kB and JNK. In the TRAF2-GSTP1 complex, TRAF2 serves as the signaling scaffold that is modulated by GSTP1.
GSTP1: The Glutathione S-Transferase
In simple terms: GSTP1 is an enzyme that normally helps detoxify harmful molecules.
GSTP1 (glutathione S-transferase pi 1) is a phase II detoxification enzyme that conjugates glutathione to electrophilic compounds. Beyond its catalytic role, GSTP1 can interact with signaling proteins, and its binding to TRAF2 is thought to disrupt TNF signaling. This interaction is fine-tuned by ligand binding, indicating that GSTP1's conformation or substrate status influences complex formation.
Assembly and Stoichiometry
In simple terms: The two proteins come together to form a functional unit.
The TRAF2-GSTP1 complex is a heteromeric assembly of TRAF2 and GSTP1. The exact stoichiometry is not fully defined, but the interaction is specific and can be detected in situ. Ligand binding to GSTP1 modulates the interaction, suggesting that the complex is dynamic and responsive to cellular redox state.
In Situ Detection
In simple terms: Scientists can see where the complex forms inside cells.
The TRAF2-GSTP1 complex can be detected in situ using techniques such as proximity ligation assay or fluorescence resonance energy transfer (FRET). This allows researchers to study the spatial and temporal dynamics of complex formation in response to stimuli.
Key Genes Involved in GO:0097057 TRAF2-GSTP1 complex
The following genes and proteins are central to the TRAF2-GSTP1 complex and its related signaling pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRAF2 | TNF receptor-associated factor 2; adaptor in TNF signaling | Core component of the complex; modulates NF-kB and JNK |
| GSTP1 | Glutathione S-transferase pi 1; detoxification enzyme | Core component; interacts with TRAF2 to disrupt TNF signaling |
| TNF | Tumor necrosis factor; cytokine ligand | Triggers TNF signaling cascade that the complex down-regulates |
| TNFRSF1A | TNF receptor superfamily member 1A | Receptor that initiates TNF signaling upstream of TRAF2 |
| TNFRSF1B | TNF receptor superfamily member 1B | Alternative TNF receptor that can recruit TRAF2 |
| MAP3K1 | Mitogen-activated protein kinase kinase kinase 1 | Downstream of TRAF2 in JNK pathway |
| MAPK8 | Mitogen-activated protein kinase 8 (JNK1) | JNK activation linked to nitrobenzoxadiazoles and autophagy inhibition |
| MAPK9 | Mitogen-activated protein kinase 9 (JNK2) | JNK isoform involved in stress signaling |
| NFKB1 | Nuclear factor kappa B subunit 1 | Transcription factor downstream of TRAF2 |
| RELA | RELA proto-oncogene, NF-kB subunit | NF-kB component regulated by TNF signaling |
| BECN1 | Beclin 1; autophagy regulator | Autophagy inhibition by nitrobenzoxadiazoles may involve BECN1 |
| MAP1LC3B | Microtubule-associated protein 1 light chain 3 beta | Autophagy marker; late-stage autophagy affected by JNK activation |
| SQSTM1 | Sequestosome 1 (p62) | Autophagy receptor; linked to late-stage autophagy |
| GCLC | Glutamate-cysteine ligase catalytic subunit | Glutathione synthesis; related to GSTP1 function |
| GCLM | Glutamate-cysteine ligase modifier subunit | Glutathione synthesis; related to GSTP1 function |
| JUN | Jun proto-oncogene, AP-1 transcription factor subunit | Downstream of JNK; regulates inflammatory genes |
| FOS | Fos proto-oncogene, AP-1 transcription factor subunit | Downstream of JNK; AP-1 component |
How Is TRAF2-GSTP1 complex Regulated?
The TRAF2-GSTP1 interaction is regulated by ligand binding to GSTP1, which fine-tunes the complex formation. This suggests that cellular redox status and the availability of glutathione-conjugating substrates can modulate the complex. Additionally, nitrobenzoxadiazoles activate JNK, which may indirectly affect the complex or its downstream effects on autophagy. However, the precise upstream regulators of the complex remain to be fully elucidated.
TRAF2-GSTP1 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRAF2 | Inflammatory diseases, cancer | TRAF2 knockout cell lines; TNF stimulation assays |
| GSTP1 | Cancer drug resistance, oxidative stress | GSTP1 overexpression and knockout models |
| MAPK8 | Neurodegeneration, autophagy disorders | JNK activation with nitrobenzoxadiazoles in neuronal cells |
| BECN1 | Autophagy-related diseases | BECN1 knockout or knockdown with JNK activators |
| SQSTM1 | Neurodegeneration, Paget disease | SQSTM1 mutant knock-in models |
Inflammation and TNF Signaling
The TRAF2-GSTP1 complex is thought to disrupt TNF signaling, thereby down-regulating inflammatory responses. Dysregulation of this complex could lead to excessive inflammation, contributing to chronic inflammatory diseases. Targeting the complex might offer a way to modulate TNF-driven inflammation.
Cancer
GSTP1 is overexpressed in many cancers and is involved in drug resistance. Its interaction with TRAF2 may link detoxification and survival signaling, promoting tumor cell survival. Disrupting the complex could sensitize cancer cells to chemotherapy or TNF-induced apoptosis.
Autophagy and Neurodegeneration
Nitrobenzoxadiazoles activate JNK and inhibit late-stage autophagy, a process that may involve GSTP1 and TRAF2. Impaired autophagy is linked to neurodegenerative diseases, suggesting that the complex could play a role in neuronal health.
From TRAF2-GSTP1 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TRAF2 knockout disrupt the complex and enhance TNF signaling? | TRAF2 knockout cell line (CRISPR-Cas9) |
| Does GSTP1 point mutation affect interaction with TRAF2? | GSTP1 point-mutant knock-in cells |
| Can we visualize the complex in live cells? | Knock-in of fluorescent tags (e.g., GFP) on TRAF2 or GSTP1 |
| Does overexpression of GSTP1 down-regulate TNF signaling? | GSTP1 overexpression stable cell line |
| What genes modulate the complex in a genome-wide screen? | CRISPR library screening with TNF reporter |
| Does JNK activation by nitrobenzoxadiazoles require the complex? | TRAF2 or GSTP1 knockout cells treated with nitrobenzoxadiazoles |
How to Study the TRAF2-GSTP1 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction between TRAF2 and GSTP1 | Confirm complex formation in cell lysates |
| Proximity ligation assay | In situ detection of the complex | Visualize complex in fixed cells |
| Western blot | Protein levels and phosphorylation status | Measure TRAF2, GSTP1, JNK, LC3B, p62 |
| CRISPR knockout screening | Genes affecting TNF signaling or complex stability | Identify modifiers of the complex |
| RNA-seq | Transcriptional changes upon complex disruption | Profile inflammatory gene expression |
| Autophagy flux assay | Autophagic degradation activity | Assess late-stage autophagy inhibition |
| FRET/BRET | Dynamic interaction in live cells | Study ligand-induced changes in complex |
| Mass spectrometry | Protein composition and modifications | Discover new complex components |
Proteomics and Co-Immunoprecipitation
Co-immunoprecipitation followed by mass spectrometry can identify the TRAF2-GSTP1 complex and its interacting partners. This method confirms the physical association and can reveal post-translational modifications that regulate the complex.
Proximity Ligation Assay (PLA)
PLA allows in situ detection of the TRAF2-GSTP1 complex at endogenous levels. It provides spatial information about where the complex forms in cells and can be combined with confocal microscopy.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that modulate the TRAF2-GSTP1 complex or its downstream effects on TNF signaling. These screens are powerful for discovering novel regulators.
Autophagy and JNK Assays
Western blotting for LC3B and p62, along with JNK phosphorylation assays, can measure the impact of the complex on autophagy and stress signaling. Nitrobenzoxadiazoles are useful tools to activate JNK and inhibit late-stage autophagy.
How CRISPR Can Be Used to Study GO:0097057 TRAF2-GSTP1 complex
Knockout
CRISPR-Cas9 knockout of TRAF2 or GSTP1 can abolish the complex, allowing researchers to study its loss-of-function effects on TNF signaling and inflammation. Knockout cell lines are essential for validating the complex's role in down-regulating inflammatory responses.
Point Mutation
Introducing point mutations in GSTP1 (e.g., in the active site or interaction interface) can dissect which residues are critical for TRAF2 binding. Such models help distinguish catalytic from non-catalytic functions of GSTP1 in the complex.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins (e.g., GFP) at the endogenous TRAF2 or GSTP1 loci enables in situ detection and live-cell imaging of the complex. This approach preserves physiological expression levels.
Overexpression
Overexpression of GSTP1 or TRAF2 can amplify complex formation and enhance its effects on TNF signaling. Overexpression models are useful for biochemical purification and for testing whether excess complex suppresses inflammation.
How EDITGENE Supports TRAF2-GSTP1 complex Research
Researchers studying TRAF2-GSTP1 complex-related genes often need to determine whether a candidate gene is causally involved in complex formation, TNF signaling, or inflammatory responses. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from knockout and point-mutation models to library screening and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for TRAF2-GSTP1 complex research.
Frequently Asked Questions About TRAF2-GSTP1 complex
What is the TRAF2-GSTP1 complex?
The TRAF2-GSTP1 complex (GO:0097057) is a protein complex comprising TRAF2 and GSTP1 that is thought to disrupt TNF signaling and down-regulate inflammatory responses.
What genes are involved in the TRAF2-GSTP1 complex?
The complex directly involves TRAF2 and GSTP1, but related genes include TNF, TNFRSF1A, MAPK8, and NFKB1.
What is the function of GO:0097057?
GO:0097057 describes a cellular component that down-regulates inflammatory responses by disrupting the TNF signaling cascade.
How is the TRAF2-GSTP1 complex regulated?
The interaction is fine-tuned by ligand binding to GSTP1, and can be influenced by cellular redox status and JNK activation.
What diseases are associated with the TRAF2-GSTP1 complex?
It has been linked to inflammatory diseases, cancer, and autophagy-related conditions such as neurodegeneration.
How can I study the TRAF2-GSTP1 complex in the lab?
Common methods include co-immunoprecipitation, proximity ligation assay, CRISPR knockout, and autophagy flux assays.
What is the role of GSTP1 in the complex?
GSTP1 is a glutathione S-transferase that binds TRAF2 and is thought to disrupt TNF signaling, linking detoxification to inflammation.
What is the role of TRAF2 in the complex?
TRAF2 is a TNF receptor adaptor that serves as a scaffold; its interaction with GSTP1 modulates downstream signaling.
Can CRISPR be used to study the TRAF2-GSTP1 complex?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the complex's function.
What are nitrobenzoxadiazoles and how do they relate to this complex?
Nitrobenzoxadiazoles are compounds that activate JNK and inhibit late-stage autophagy, processes that intersect with GSTP1 and TRAF2 signaling.
Conclusion
The TRAF2-GSTP1 complex (GO:0097057) is a unique cellular component that bridges glutathione metabolism and TNF signaling to down-regulate inflammation. Its dynamic regulation by ligand binding and its potential role in cancer and autophagy make it an attractive target for further study. By leveraging CRISPR-based models and advanced screening technologies, researchers can uncover the precise mechanisms and therapeutic potential of this complex.
References
- 1. De Luca A et al.. 2014. The fine-tuning of TRAF2-GSTP1-1 interaction: effect of ligand binding and in situ detection of the complex.. Cell Death Dis 5(1):e1015 PMID: 24457959
- 2. Palumbo C et al.. 2016. c-Jun N-terminal kinase activation by nitrobenzoxadiazoles leads to late-stage autophagy inhibition.. J Transl Med 14:37 PMID: 26847645
